Cite
HARVARD Citation
Poveda, A. et al. (n.d.). 1000TiPOPINION: A single-arm, open-label, phase IIIb study of olaparib maintenance monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) and without germline BRCA mutations (non-gBRCAm). Annals of oncology. p. . [Online].